PCMI
PCRX icon

Princeton Capital Management Inc’s Pacira BioSciences PCRX Stock Holding History

Princeton Capital Management Inc’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.25M Buy
33,149
+8,240
+33% +$332K 0.63% 41
2017
Q2 		$1.19M Sell
24,909
-52
-0.2% -$2.41K 0.75% 42
2017
Q1 		$1.14M Buy
24,961
+5,366
+27% +$232K 0.72% 38
2016
Q4 		$633K Buy
19,595
+3,030
+18% +$101K 0.42% 51
2016
Q3 		$567K Buy
+16,565
New +$649K 0.37% 52

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Princeton Capital Management Inc's PCRX Position: Q3 2017 in Review

Princeton Capital Management Inc increased its Pacira BioSciences (PCRX) stake by 33% in Q3 2017, buying an estimated $332K and bringing the position to 33,149 shares worth $1.25M. The position accounts for 0.63% of the portfolio, ranked #41.

Princeton Capital Management Inc first reported a position in PCRX in Q3 2016 and has held it in 5 quarters since. 180 funds tracked by Wall St. Rank hold PCRX as of Q3 2017.

  • Princeton Capital Management Inc held 33,149 shares of Pacira BioSciences worth $1.25M as of Q3 2017.
  • Princeton Capital Management Inc bought 8,240 Pacira BioSciences shares in Q3 2017, an estimated $332K.
  • Pacira BioSciences made up 0.63% of Princeton Capital Management Inc's portfolio in Q3 2017, its #41 holding.
  • Princeton Capital Management Inc first reported a position in Pacira BioSciences in Q3 2016 and has held it in 5 quarters since.
  • 180 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.